Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

QuantiFERON (R)-CMV for immune-monitoring after allogeneic stem cell transplantation: preliminary data

Morello E.
Cavattoni I.
Pagani E
Coin S.
Cortelazzo S
Larcher C.
Tridente G.
MONSURRO', Vladia

Publication date

January 2008

Abstract

We studied the application of Quantiferon CMV as monitoring of CMV riactivation after bone marrow transplantatio

Extracted data

Related items

QuantiFERON‐cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Thompson, G.
Boan, P.
Purtill, D.
Cooney, J.
Cannell, P.
Wright, M.
John, M.

January 2022

Background Controlling cytomegalovirus (CMV) infection through prophylaxis or pre-emptive therapy...

Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants

Abate, Davide
Saldan, Alda
Forner, Gabriella
Tinto, Daniel
Bianchin, Alice
Palu, Giorgio

February 2014

Assessing the CMV specific CMI in transplant subjects represents a promising strategy to determine t...

Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ-transplantation

van den Berg, A. P.
Tegzess, A. M.
Scholten-Sampson, A.
Schirm, J.
van der Giessen, M.
The, T. Hauw
van Son, W. J.

May 1992

We investigated the value of monitoring CMV antigenemia during and after antiviral therapy for CMV d...

Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.

Siok-Keen Tey
Glen A Kennedy
Deborah Cromer
Miles P Davenport
Susan Walker
Linda I Jones
Tania Crough
Simon T Durrant
James A Morton
Jason P Butler
Ashish K Misra
Geoffrey R Hill
Rajiv Khanna

The reconstitution of anti-viral cellular immunity following hematopoietic stem cell transplantation...

Immune Monitoring for CMV in Transplantation.

Yong, M.K.
Lewin, S.R.
Manuel, O.

March 2018

Immune monitoring to determine when and how the recovery of cytomegalovirus (CMV)-specific T-cells o...

Patients with CMV Infection Complications

Stem Cell Transplant
Siok-keen Tey
Glen A. Kennedy
Deborah Cromer
Miles P. Davenport
Susan Walker
Linda I. Jones
Tania Crough
Simon T. Durrant
James A. Morton
Jason P. Butler
Ashish K. Misra
Geoffrey R. Hill
Rajiv Khanna

August 2016

The reconstitution of anti-viral cellular immunity following hematopoietic stem cell transplantation...

Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection

February 2019

none11noBackground: The clinical utility of QuantiFERON®-CMV (QFN®-CMV) assay in heart transplant r...

The QuantiFERON Monitor (R) assay is predictive of infection post allogeneic hematopoietic cell transplantation

Douglas, AP
Yu, L
Sundararajan, V
Szer, J
Ritchie, D
Slavin, MA
Sasadeusz, J
Visvanathan, K

February 2020

INTRODUCTION: Following allogeneic hematopoietic stem cell transplantation (alloHCT), excessive immu...

Global and CMV-specific Immune Assays to Predict Clinical Outcomes and Inform Clinical Practice in Solid Organ Transplant Recipients

Mian, Muhtashim

November 2016

Solid organ transplantation is an effective procedure for the treatment of end-stage organ failure. ...

Performance of the QuantiFERON-Cytomegalovirus (CMV) Assay for Detection and Estimation of the Magnitude and Functionality of the CMV-Specific Gamma Interferon-Producing CD8 T-Cell Response in Allogeneic Stem Cell Transplant Recipients

Valencia Spaind

October 2016

The performance of the QuantiFERON-cytomegalovirus (CMV) assay was compared to that of a flow cytome...

Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia

Thompson, G.
Boan, P.
Baumwol, J.
Chakera, Aron
MacQuillan, G.
Swaminathan, S.
Lavender, M.
Flexman, J.
James, I.
John, M.

January 2018

Prevention of cytomegalovirus (CMV) infection remains an important aspect of improving long term out...

Immune Monitoring for CMV in Transplantation

Yong, MK
Lewin, SR
Manuel, O

April 2018

PURPOSE OF REVIEW: Immune monitoring to determine when and how the recovery of cytomegalovirus (CMV)...

CMV DNA e MRNA Pp67 nel monitoraggio del paziente sottoposto a trapianto di midollo osseo

Maria Bonaria Goffi

March 2004

Primary infection of immunocompetent individuals does not lead to complication, but CMV is a major c...

Comparison of CMV ELISPOT and CMV Quantiferon\u2122 interferon-\u3b3 releasing assays in assessing risk of CMV infection in kidney transplant recipients.

Abate, DAVIDE ANTONIO
Saldan, A
Mengoli, C
Fiscon, M
Silvestre, C
Fallico, L
Peracchi, M
Furian, Lucrezia
Cusinato, R
Bonfante, Luciana
Rossi, B
Marchini, F
Sgarabotto, D
Rigotti, Paolo
Palu', Giorgio

January 2013

Background.Assessing the CMV specific cell-mediated immunity (CMI) represents an appealing strategy ...

Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation

Borchers Sylvia
Bremm Melanie
Lehrnbecher Thomas
Dammann Elke
Pabst Brigitte
Wölk Benno
Esser Ruth
Yildiz Meral
Eder Matthias
Stadler Michael
Bader Peter
Martin Hans
Jarisch Andrea
Schneider Gisbert
Klingebiel Thomas
Ganser Arnold
Weissinger Eva M.
Koehl Ulrike

December 2012

T cells (CMV-CTLs) after allogeneic hematopoietic stem cell transplantation (HSCT) is necessary to ...

QuantiFERON‐cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Thompson, G.
Boan, P.
Purtill, D.
Cooney, J.
Cannell, P.
Wright, M.
John, M.

January 2022

Background Controlling cytomegalovirus (CMV) infection through prophylaxis or pre-emptive therapy...

Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants

Abate, Davide
Saldan, Alda
Forner, Gabriella
Tinto, Daniel
Bianchin, Alice
Palu, Giorgio

February 2014

Assessing the CMV specific CMI in transplant subjects represents a promising strategy to determine t...

Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ-transplantation

van den Berg, A. P.
Tegzess, A. M.
Scholten-Sampson, A.
Schirm, J.
van der Giessen, M.
The, T. Hauw
van Son, W. J.

May 1992

We investigated the value of monitoring CMV antigenemia during and after antiviral therapy for CMV d...

Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.

Siok-Keen Tey
Glen A Kennedy
Deborah Cromer
Miles P Davenport
Susan Walker
Linda I Jones
Tania Crough
Simon T Durrant
James A Morton
Jason P Butler
Ashish K Misra
Geoffrey R Hill
Rajiv Khanna

The reconstitution of anti-viral cellular immunity following hematopoietic stem cell transplantation...

Immune Monitoring for CMV in Transplantation.

Yong, M.K.
Lewin, S.R.
Manuel, O.

March 2018

Immune monitoring to determine when and how the recovery of cytomegalovirus (CMV)-specific T-cells o...

Patients with CMV Infection Complications

Stem Cell Transplant
Siok-keen Tey
Glen A. Kennedy
Deborah Cromer
Miles P. Davenport
Susan Walker
Linda I. Jones
Tania Crough
Simon T. Durrant
James A. Morton
Jason P. Butler
Ashish K. Misra
Geoffrey R. Hill
Rajiv Khanna

August 2016

The reconstitution of anti-viral cellular immunity following hematopoietic stem cell transplantation...

Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection

February 2019

none11noBackground: The clinical utility of QuantiFERON®-CMV (QFN®-CMV) assay in heart transplant r...

The QuantiFERON Monitor (R) assay is predictive of infection post allogeneic hematopoietic cell transplantation

Douglas, AP
Yu, L
Sundararajan, V
Szer, J
Ritchie, D
Slavin, MA
Sasadeusz, J
Visvanathan, K

February 2020

INTRODUCTION: Following allogeneic hematopoietic stem cell transplantation (alloHCT), excessive immu...

Global and CMV-specific Immune Assays to Predict Clinical Outcomes and Inform Clinical Practice in Solid Organ Transplant Recipients

Mian, Muhtashim

November 2016

Solid organ transplantation is an effective procedure for the treatment of end-stage organ failure. ...

Performance of the QuantiFERON-Cytomegalovirus (CMV) Assay for Detection and Estimation of the Magnitude and Functionality of the CMV-Specific Gamma Interferon-Producing CD8 T-Cell Response in Allogeneic Stem Cell Transplant Recipients

Valencia Spaind

October 2016

The performance of the QuantiFERON-cytomegalovirus (CMV) assay was compared to that of a flow cytome...

Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia

Thompson, G.
Boan, P.
Baumwol, J.
Chakera, Aron
MacQuillan, G.
Swaminathan, S.
Lavender, M.
Flexman, J.
James, I.
John, M.

January 2018

Prevention of cytomegalovirus (CMV) infection remains an important aspect of improving long term out...

Immune Monitoring for CMV in Transplantation

Yong, MK
Lewin, SR
Manuel, O

April 2018

PURPOSE OF REVIEW: Immune monitoring to determine when and how the recovery of cytomegalovirus (CMV)...

CMV DNA e MRNA Pp67 nel monitoraggio del paziente sottoposto a trapianto di midollo osseo

Maria Bonaria Goffi

March 2004

Primary infection of immunocompetent individuals does not lead to complication, but CMV is a major c...

Comparison of CMV ELISPOT and CMV Quantiferon\u2122 interferon-\u3b3 releasing assays in assessing risk of CMV infection in kidney transplant recipients.

Abate, DAVIDE ANTONIO
Saldan, A
Mengoli, C
Fiscon, M
Silvestre, C
Fallico, L
Peracchi, M
Furian, Lucrezia
Cusinato, R
Bonfante, Luciana
Rossi, B
Marchini, F
Sgarabotto, D
Rigotti, Paolo
Palu', Giorgio

January 2013

Background.Assessing the CMV specific cell-mediated immunity (CMI) represents an appealing strategy ...

Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation

Borchers Sylvia
Bremm Melanie
Lehrnbecher Thomas
Dammann Elke
Pabst Brigitte
Wölk Benno
Esser Ruth
Yildiz Meral
Eder Matthias
Stadler Michael
Bader Peter
Martin Hans
Jarisch Andrea
Schneider Gisbert
Klingebiel Thomas
Ganser Arnold
Weissinger Eva M.
Koehl Ulrike

December 2012

T cells (CMV-CTLs) after allogeneic hematopoietic stem cell transplantation (HSCT) is necessary to ...

QuantiFERON‐cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

Thompson, G.
Boan, P.
Purtill, D.
Cooney, J.
Cannell, P.
Wright, M.
John, M.

January 2022

Background Controlling cytomegalovirus (CMV) infection through prophylaxis or pre-emptive therapy...

Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants

Abate, Davide
Saldan, Alda
Forner, Gabriella
Tinto, Daniel
Bianchin, Alice
Palu, Giorgio

February 2014

Assessing the CMV specific CMI in transplant subjects represents a promising strategy to determine t...

Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ-transplantation

van den Berg, A. P.
Tegzess, A. M.
Scholten-Sampson, A.
Schirm, J.
van der Giessen, M.
The, T. Hauw
van Son, W. J.

May 1992

We investigated the value of monitoring CMV antigenemia during and after antiviral therapy for CMV d...